Baseline fibroblast growth factor 23 is associated with long-term mortality in ST-elevation myocardial infarction-results from the augsburg myocardial infarction registry.
Frontiers in cardiovascular medicine（2023）
Abstract
FGF-23 is independently associated with long-term mortality after STEMI and might play an important role in the response to myocardial injury. The results suggest FGF-23 to be a useful marker in the long-term treatment of STEMI patients and a potential target for drug development.
MoreTranslated text
Key words
baseline fibroblast growth factor,fibroblast growth factor,myocardial infarction—results,growth factor,augsburg,long-term,st-elevation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined